4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-002549
President and CEO gave up 7,484 shares (to pay taxes)
- President and CEO acquired 25,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luly Jay R. President and CEO | 2025-02-12 | Grant or award | +25,500 | 872,138 | D: show line 1 in the form | ||
| Luly Jay R. President and CEO | 2025-02-12 | Shares withheld for taxes | −7,484 | $5.59 | $41,836 | 864,654 | D: show line 2 in the form |
Loading xslF345X05/form4.xml…